V
Vital Connect
Develops a wearable biosensor technology recording patients' vital signs for wireless hospital and remote patient monitoring
About Vital Connect
VitalConnect is a healthcare technology startup that specializes in remote patient monitoring. The company has developed a biosensor called VitalPatch, which allows healthcare providers to continuously monitor the vital signs of patients in real-time. This technology is particularly useful for cardiac monitoring, enabling doctors to track heart health remotely and intervene when necessary.
VitalConnect serves a diverse range of clients, including hospitals, clinics, and healthcare professionals who are involved in both inpatient and outpatient care. The company also caters to patients with chronic diseases and those participating in clinical trials. By providing real-time data, VitalConnect helps healthcare providers make informed decisions, improving patient outcomes and optimizing the delivery of care.
The market VitalConnect operates in is the healthcare technology sector, specifically focusing on remote patient monitoring and telehealth solutions. This market is growing rapidly due to the increasing demand for remote healthcare services, driven by factors such as the aging population and the need for efficient chronic disease management.
VitalConnect's business model revolves around selling its VitalPatch biosensor and the accompanying telehealth software. The company generates revenue through the sale of these products and possibly through subscription-based services for continuous monitoring and data analytics. By offering a comprehensive solution that includes both hardware and software, VitalConnect ensures a steady stream of income while providing significant value to its clients.
In summary, VitalConnect is revolutionizing patient care with its innovative remote monitoring solutions, making healthcare more accessible and efficient.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- San Jose, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
HHS Administration for Strategic Preparedness and Response
Series A2 investors entered at this stage
Michael Kantor
Perceptive Advisors
Series B and later9 investors entered at this stage
Armentum Partners
Oxford Finance
EW Healthcare Partners- HCHealth Insight Capital
Revelation Partners- PVPacific General Ventures
Trinity Capital
Ally Bridge Group
MVM Life Science Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vital Connect on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vital Connect on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.